Interaction between poly(ADP-ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease risk

Dementia and Geriatric Cognitive Disorders

Volumn 23, Issue 4, 2007, Pages 215-218

  Infante, Jon ^a   Llorca, Javier ^b   Mateo, Ignacio ^a   Rodríguez Rodríguez, Eloy ^a   Sánchez Quintana, Coro ^a   Sánchez Juan, Pascual ^a   Fernández Viadero, Carlos ^c   Peña, Nicolás ^c   Berciano, José ^a   Combarros, Onofre ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c Consejería de Sanidad ^*  (Spain)

Author keywords

Alzheimer's disease; Gene polymorphism; Interleukin 1A; Poly(ADP ribose) polymerase 1

Indexed keywords

INTERLEUKIN 1ALPHA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SPAIN;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-1ALPHA; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLY(ADP-RIBOSE) POLYMERASES; POLYMORPHISM, GENETIC; REFERENCE VALUES; RISK FACTORS;

EID: 33947691675     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099471     Document Type: Article

References (14)

1. Wyss-Coray T, Mucke L: Inflammation in neurodegenerative disease: a double-edged sword. Neuron 2002;35:419-432.
2. Chiarugi A, Moskowitz MA: Poly(ADP-ribose) polymerase-1 activity promotes NF-κB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem 2003;85:306-317.
3. Kauppinen TM, Swanson RA: Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. J Immunol 2005;174:2288-2296.
4. Love S, Barber R, Wilcock GK: Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease. Brain 1999;122:247-253.
5. Masutani M, Nakagama H, Sugimura T: Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease. Cell Mol Life Sci 2005;62:769-783.
6. McKhaan G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:934-944.
7. Combarros O, Sánchez-Guerra M, Infante J, Llorca J, Berciano J: Gene dose-dependent association of interleukin-1A -889 allele 2 polymorphism with Alzheimer's disease. J Neurol 2002;249:1242-1245.
8. Solé X, Guinó E, Valls J, Iniesta R, Moreno V: SPNStats: a web tool for the analysis of association studies. Bioinformatics 2006;22: 1928-1929.
9. Moore JH: The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 2003;56:73-82.
10. Pascual M, López-Nevot MA, Cáliz R, Ferrer MA, Balsa A, Pascual-Salcedo D, Martín J: A poly(ADP-ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis. Arthritis Rheum 2003;48:638-641.
11. Rueda B, Koeleman BPC, López-Nevot MA, Ortega E, Maldonado J, López M, Polanco I, Martín J: Poly(ADP-ribose) polymerase-1 haplotypes are associated with coeliac disease. Int J Immunogenet 2005;32:245-248.
12. Ha HC: Defective transcription factor activation for proinflammatory gene expression in poly(ADP-ribose) polymerase 1-deficient glia. Proc Natl Acad Sci USA 2004;101:5087-5092.
13. Mrak RE, Griffin WST: Interleukin-1 and the immunogenetics of Alzheimer disease. J Neuropathol Exp Neurol 2000;59:471-476.
14. Hayes A, Green EK, Pritchard A, Harris JM, Zhang Y, Lambert JC, Chartier-Harlin MC, Pickering-Brown SM, Lendon CL, Mann DMA: A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:1475-1477.